Address correspondence to Misty J. Eaton, Ph.D. or Serguei Skatchkov, Ph.D., Department of Biochemistry, Universidad Central del Caribe, PO Box 60327, Bayamón, PR 00960-6032, U.S.A. E-mail: email@example.com or firstname.lastname@example.org
Purpose: KCNJ10 encodes subunits of inward rectifying potassium (Kir) channel Kir4.1 found predominantly in glial cells within the brain. Genetic inactivation of these channels in glia impairs extracellular K+ and glutamate clearance and produces a seizure phenotype. In both mice and humans, polymorphisms and mutations in the KCNJ10 gene have been associated with seizure susceptibility. The purpose of the present study was to determine whether there are differences in Kir channel activity and potassium- and glutamate-buffering capabilities between astrocytes from seizure resistant C57BL/6 (B6) and seizure susceptible DBA/2 (D2) mice that are consistent with an altered K+ channel activity as a result of genetic polymorphism of KCNJ10.
Methods: Using cultured astrocytes and hippocampal brain slices together with whole-cell patch-clamp, we determined the electrophysiologic properties, particularly K+ conductances, of B6 and D2 mouse astrocytes. Using a colorimetric assay, we determined glutamate clearance capacity by B6 and D2 astrocytes.
Results: Barium-sensitive Kir currents elicited from B6 astrocytes are substantially larger than those elicited from D2 astrocytes. In addition, potassium and glutamate buffering by D2 cortical astrocytes is impaired, relative to buffering by B6 astrocytes.
Discussion: In summary, the activity of Kir4.1 channels differs between seizure-susceptible D2 and seizure-resistant B6 mice. Reduced activity of Kir4.1 channels in astrocytes of D2 mice is associated with deficits in potassium and glutamate buffering. These deficits may, in part, explain the relatively low seizure threshold of D2 mice.
In both mice and humans, polymorphisms or mutations in KCNJ10, the gene encoding Kir4.1 subunits, have been associated with seizures. Initially, quantitative trait loci (QTL) mapping in C57BL/6J (B6) and DBA/2J (D2) mice identified a distal chromosome 1 locus that has a major effect on maximal electroshock seizure threshold (MEST) (Ferraro et al., 2001), a classical measure of seizure susceptibility. The QTL was fine-mapped to a 6 Mb critical interval (Ferraro et al., 2004) and the creation of transgenic mouse lines supported Kcnj10 (Kir4.1) as a quantitative trait gene at this locus (Ferraro et al., 2007). An amino acid substitution at position 262 of Kir4.1 (threonine in B6, serine in D2) is postulated to contribute to the genetic mechanism involved in the control of seizure susceptibility in mice (Ferraro et al., 2004). In humans, a nearby amino acid substitution in Kir4.1, Arg271Cys, has been shown to be associated with common forms of epilepsy in two independent studies, such that control individuals are significantly more likely to harbor the minor Cys allele (Buono et al., 2004; Lenzen et al., 2005). Interestingly, neither mouse nor human Kir4.1 variants described earlier alter the biophysical properties of inward rectifying potassium channels (Shang et al., 2005). Very recently, rare mutations that substantially reduce channel conductance have been identified as the cause of severe clinical syndromes that include epilepsy (Bockenhauer et al., 2009; Scholl et al., 2009).
The purpose of the present study was to determine whether astrocytes derived from B6 and D2 mice differ with regard to Kir channel activity and their capabilities for buffering potassium and glutamate, and whether any such differences might be consistent with differences in their respective seizure susceptibility.
In vitro slice experiments utilized male mice from the strains B6 and D2 purchased from Charles River Laboratories (Wilmington, MA, U.S.A.). Experiments with cultured astrocytes utilized both male and female mice. Mice were maintained on a 12 h light/dark schedule and had access to food and water ad libitum. All experiments were approved by the Institutional Animal Care and Use Committee.
Electrophysiology recording from cultured astrocytes
Primary cultures of astrocytes were prepared from neocortex of 1–2 days old mice as described previously (Kucheryavykh et al., 2007). Membrane currents were measured with the single electrode whole-cell patch-clamp technique. Two Narishige hydraulic micromanipulators (MMW-203; Narishige, Tokyo, Japan) were used for (1) voltage-clamp recording, and (2) positioning a micropipette with 30–50 μm tip diameter for application of test solutions. A five-valve system for fast drug application (MS Concentration Clamp; VS-2001, Vibraspec, PA, U.S.A.), controlled by a second computer, was connected to the outlets.
Electrodes from hard glass (GC-150-10 glass tubing; Clark Electromedical Instruments, Kent, United Kingdom) were pulled in four steps using a Sutter P-97 puller (Sutter Instruments, Novato, CA, U.S.A.). After filling with intracellular solution containing (in mm): 141 KCl, 1 MgCl2, 1 CaCl2, 10 EGTA, 10 HEPES, 3 Na2ATP, 0.25 spermine HCl, pH adjusted to 7.2 with NaOH/HCl, they had resistances of 4–6 MΩ; after cell penetration, the access resistance was 10–15 MΩ, compensated by at least 75%. The extracellular solution contained (in mm): 138 NaCl, 2 CaCl2, 1.9 MgCl2, and 10 HEPES; KCl varied from 1–30 mm (substituted by NaCl to adjust osmolarity to 308 mOsm). High frequencies (>1 kHz) were cut off, using an Axopatch-200B amplifier and a CV-203BU headstage, and digitized at 5 kHz through a DigiData 1200A interface (Axon Instruments, Sunnyvale, CA, U.S.A.). The pClamp 9 software (Axon Instruments) was used for data acquisition and analysis.
The membrane potentials were determined immediately after attainment of whole-cell mode, and cells were then subsequently held under voltage-clamp at this potential. Applications of solutions with increased K+ were used to assess potassium uptake ability of the cell as the shift in inward current following shift in [K+]o from 3–10 or 30 mm (Skatchkov et al., 1999).
Electrophysiologic recording from astrocytes in brain slices
Male B6 and D2 mice (30–72 days postnatal) were decapitated, and horizontal slices (250 μm) containing the hippocampal area were prepared using a Vibratome (VT1000S; Leica, Berlin, Germany). Slices were cut in ice-cold oxygenated artificial cerebrospinal fluid (ACSF) containing (in mm): 127 NaCl; 2.5 KCl; 1.25 NaH2PO4; 25 NaHCO3; 2 CaCl2; 1 MgCl2; and 25 d-glucose. The solution was saturated with 95%O2–5%CO2 to achieve pH 7.4. For the test application, external KCl (10 mm) or KCl (10 mm) with BaCl2 (100 μm) was added to ACSF.
Membrane currents were measured with the single electrode whole-cell patch-clamp technique. Borosilicate glass patch pipettes (O.D. 1.5 mm, I.D. 1.0 mm; WPI, Sarasota, FL, U.S.A.) were pulled to a final resistance of 8–10 MΩ for astrocyte recordings in four steps using a Sutter P-97 puller (Sutter Instruments). The intracellular solution contained (in mm): 130 K-gluc, 10 Na-gluc, 4 NaCl, 4 phosphocreatine, 0.3 GTP-Na, 4 Mg–ATP, and 10 HEPES, and the pH was adjusted to 7.2 with KOH. Cells in the hippocampal CA1 area were visualized using an Olympus infrared microscope equipped with DIC (BX51WI; Olympus, Tokyo, Japan). Two motorized micromanipulators (MX7500 with MC-1000 drive; Siskiyou, Grants Pass, OR, U.S.A.) were used for voltage-clamp and current-clamp recording. A two-channel MultiClamp 700A patch-clap amplifier with DigiData 1322A interface (Axon Instruments) was used for recording and stimulation. The pClamp 9 software (Axon Instruments) was used for data acquisition and analysis.
Colorimetric assay to assess glutamate clearance by astrocytes
To evaluate the glutamate clearance capacity, astrocyte cultures were grown in 24-well dishes. Glutamate remaining in the medium was determined as we have previously described (Kucheryavykh et al., 2007, 2009) using the protocol of Abe et al. (2000). Briefly, medium in each well of the dish was replaced with 250 μl of serum-free medium containing 400 μm glutamate. After 60 min, the medium was removed and 50 μl of culture supernatant was transferred to 96-well culture plates and mixed with 50 μl of substrate mixture (20 U/ml glutamate dehydrogenase, 2.5 mg/ml β-nicotinamide adenine dinucleotide (NAD), 0.25 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT), 100 μm 1-methoxyphenazine methosulfate (MPMS), 0.1% (v/v) Triton X-100, and 0.2 m Tris–HCl, pH 8.2). Glutamate dehydrogenation was allowed to proceed for 10 min at 37°C and then stopped by adding 100 μl of a solution containing 50% dimethylformamide and 20% sodium dodecyl sulfate (pH 4.7). The production of MTT formazan was assessed by measurement of absorbance at 550 nm using a microplate reader. A standard curve was constructed in each assay using cell-free culture medium containing known concentrations of glutamate. The concentration of extracellular glutamate in the samples was estimated from the standard curve. As a control for each experiment, serum-free medium containing 400 μm glutamate was added to empty wells of a 24 well dish (no astrocytes) and processed together with the astrocytes, that is, 60 min in the incubator until sample collection. In our hands, the lower limit of sensitivity of this assay is approximately 75 μm glutamate. The concentration of glutamate remaining in the medium is a reflection of glutamate taken up by the astrocytes, as well as that released from the astrocytes.
TBOA ((3S)-3-[[3-[[4-(trifluoromethyl) benzoyl]amino] phenyl]methoxy]-l-aspartic acid) was purchased from Tocris Bioscience (Bristol, United Kingdom). All other chemicals were purchased from Sigma Chemical Company (St. Louis, MO, U.S.A.).
The Student’s t-test for independent samples was used to analyze electrophysiologic data, whereas one-way analysis of variance (ANOVA) followed by Tukey’s (Multiple Comparison Test) was used to analyze the glutamate clearance experiments.
Because genetic polymorphisms in KCNJ10 (gene encoding for Kir4.1 channels) have been implicated in seizure susceptibility differences between C57BL/6J (B6) and DBA/2J (D2) mice, we examined the Kir channel activity in cultured cortical astrocytes from B6 and D2 mice to see if it differed between the two mouse strains. Astrocytes were perfused with a physiologic salt solution containing 3 mm K+ and dialyzed with a pipette solution containing 150 mm K+. Under these conditions, application of 100 ms steps to potentials between −100 and +100 mV from a holding potential equal to the resting membrane potential evoked both inward and outward currents that were substantially larger in B2 astrocytes than those elicited in D2 astrocytes (Fig. 1). Upon application of the Kir channel blocker, Ba2+ (200 μm), currents in astrocytes from B6 mice were inhibited, particularly in the inward direction (Fig. 1A,B1,B2), but there was little effect on the current–voltage curve of D2 astrocytes (Fig. 1C,D1,D2). Taken together, the smaller current elicited from D2 astrocytes and the lack of response to barium application indicate that functional (membrane) Kir channel activity is substantially reduced in astrocytes of D2 mice as compared with activity in B6 astrocytes.
We next assessed the ability of cultured astrocytes to buffer potassium by measuring membrane currents in response to extracellular [K+] steps (Skatchkov et al., 1999; Zhou & Kimelberg, 2000). The astrocytes were used for studies 3 weeks after plating. To measure the currents evoked by different physiologic and pathologic [K+]o, extracellular solutions with 1, 10, and 30 mm K+ (normal bath = 3 mm K+) were applied (“K+ steps”; duration of step = 1–1.5 s). Figure 2 summarizes the current response to K+ steps. The inward currents in response to 10 and 30 mm K+ steps in D2 astrocytes were <20% of currents elicited from B6 astrocytes, indicating that the ability of D2 astrocytes to take up K+ was impaired substantially.
We next examined the activity of Kir channels in astrocytes in brain slices. These studies were done for two reasons. The first was to demonstrate that the differences in Kir channel activity and potassium uptake by astrocytes of B6 and D2 mice were not due to anomalies resulting from the use of cultured astrocytes. The second was to be able to correlate the findings using mice of similar age as those used for seizure susceptibility studies (Ferraro et al., 1998). It has been shown that Kir4.1 channel expression is stable in glia by 2 weeks (Schopf et al., 2004; Seifert et al., 2009). The present experiment utilized 30–72 day-old mice in which Kir4.1 channel expression was at maximal levels and could, therefore, be directly compared with the 56–63 days old mice used by Ferraro et al. (1998).
Using whole-cell voltage clamp to record from astrocytes in stratum radiatum area of hippocampal slices from B6 and D2 mouse, we measured inward K+ current in response to switching the external solution from one containing 2.5 mm K+ to one containing 10 mm K+ (Fig. 3A), in the presence and absence of 100 μm Ba2+. At this concentration, Ba2+ is a relatively selective blocker of Kir channels. We found that there was significantly less barium-sensitive Kir current in D2 astrocytes (Fig. 3B), consistent with the data obtained using cultured astrocytes.
Because decreased expression of Kir4.1 channel subunits has been shown to cause decreased glutamate transport by astrocytes (Djukic et al., 2007; Kucheryavykh et al., 2007), we next examined the glutamate uptake capability of cultured astrocytes from B6 and D2 mice. In preliminary experiments (not shown), we identified a time-dependent reduction in glutamate in the medium over 120 min of incubation, but no change in dishes that do not contain astrocytes. Based on these preliminary experiments, we assessed glutamate concentration remaining in the medium 60 min after incubation with 250 μl of serum-free culture medium containing 400 μm glutamate, with the presence or absence of the glutamate transporter inhibitor TBOA (200 μm). Glutamate concentrations in the medium of B6 and D2 astrocytes were reduced by 53% and 37%, respectively (Fig. 4). This indicates that glutamate clearance by D2 astrocytes was less efficient than that by B6 astrocytes. In addition, glutamate clearance by both B6 and D2 astrocytes was eliminated by addition of TBOA (Fig. 4). This suggests that the differences in glutamate clearance by B6 and D2 astrocytes are due to differences in glutamate transporter function and not glutamate release mechanisms. Furthermore, the differences in glutamate clearance are not due to increased astrocytic cell death in D2 astrocytes upon application of glutamate. Using the Invitrogen Live/Dead Viability/Cytotoxicity kit, we observed virtually 100% viability of both B6 and D2 astrocytes after 60 min incubation in 400 μm glutamate (data not shown).
There are two major ways that a missense variation could alter Kir channel activity. The first is by decreasing K+ conductance through the channel. Surprisingly, when these variants (Kir4.1 Thr262 and Kir4.1 Ser262) were expressed in Xenopus oocytes (either as homomeric Kir4.1 channels or heteromeric Kir4.1/Kir5.1 channels) and compared, there was no difference in overall current in oocytes, response to intracellular acidification, inhibition by extracellular barium, or single channel properties (Shang et al., 2005). Furthermore, we have found that there are no differences in the rectification properties of either the threonine or serine variant of Kir4.1 when transiently expressed in tsA201 cells (Eaton et al., 2009). Taken together, these data suggest that the Thr262Ser variation of Kir4.1 channels does not alter the overall biophysical properties and K+ conductance through the channel.
An alternative way to reduce Kir channel activity is by decreasing the overall cell surface expression of Kir4.1 channels in astrocytes. Reduction in Kir4.1 channels is consistent with what is seen in some epilepsies, such as Ammon’s horn sclerosis (Hinterkeuser et al., 2000; Schröder et al., 2000). Furthermore, reduction of Kir4.1 channels in astrocytic plasma membrane has been shown to reduce K+ and glutamate clearance by astrocytes (Djukic et al., 2007; Kucheryavykh et al., 2007).
Some of the polymorphisms associated with seizure susceptibility that occur in the KCNJ10 gene, in both humans and mice, cause alterations of amino acids predicted to be located in a cytoplasmic domain of the ion channel (Shang et al., 2005) and potentially involved in channel trafficking. Surface expression of mammalian Kir channels is tightly regulated by their cytoplasmic domains with specific amino acid sequences in both the N-terminal and C-terminal regions of Kir4.1 subunits that control intracellular protein trafficking (Stockklausner & Klöcker, 2003). It has been reported that short amino acid sequences in the C-terminus control trafficking between the endoplasmic reticulum and the Golgi complex, whereas the proximal N-terminus controls the ability of the protein to be transported from the Golgi and to reach the cell membrane. The lack of appropriate sequence information in these regions results in accumulation of the protein intracellularly and a significant decrease in cell surface expression (Stockklausner & Klöcker, 2003). Furthermore, interactions with co-expressed proteins have been shown to be involved in transport of Kir4.1 to the cell membrane as well as in the normal clustered pattern of channel distribution (Connors & Kofuji, 2002; Connors et al., 2004; Noël et al., 2005). Therefore, it is possible that the common mouse (Thr272Ser) and human (Arg271Cys) amino acid substitutions in Kir4.1 influence seizure susceptibility by virtue of their ability to affect the kinetics of intracellular Kir4.1 transport and/or membrane targeting, but this will require further studies of subunit trafficking in native tissues.
In summary, the activity of Kir4.1 channels differs between seizure-susceptible D2 and seizure-resistant B6 mice. Reduced activity of Kir4.1 channels in astrocytes of D2 mice is associated with deficits in potassium and glutamate buffering. These deficits may, in part, explain the relatively low seizure threshold of D2 mice.
The authors thank Paola López Pieraldi and Natalia Skachkova for their superior technical assistance. This publication was made possible by NIH grant numbers S11-NS48201 (MJE), U54 NS039408 (SNS), S06 GM050695 (SNS, MJE), G12 RR03035 (for facilities at UCC) and R01 NS40554 (TNF) from NINDS, NIGMS and NCRR. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH. The Coatesville Veteran’s Affairs Medical Center animal facilities and resources were used to support some of this work. The contents do not reflect the official views of the Department of Veteran Affairs or any other US government agency.
None of the authors has any conflict of interest to disclose. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.